Open AccessRomosozumab for the treatment of osteoporosis in women: Efficacy, safety, and cardiovascular risk
Author(s) -
Sian Yik Lim
Publication year - 2022
Publication title -
women's health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.363
H-Index - 39
eISSN - 1745-5065
pISSN - 1745-5057
DOI - 10.1177/17455057221125577
Subject(s) - sclerostin , medicine , osteoporosis , wnt signaling pathway , signal transduction , chemistry , biochemistry